skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Posttherapeutic cerebral radionecrosis: a complication of head and neck tumor therapy

Journal Article · · South. Med. J.; (United States)

Patients with treated head and neck cancer may have focal neurologic symptoms and personality changes due to delayed cerebral radionecrosis. A history of past treatment should direct the physician to consider these lesions in the differential diagnosis. Craniotomy is the management recommended. Histopathologic changes include fibrotic response of the meninges with pleomorphic and vacuolated fibroblasts, capillary hyperplasia, reactive astrocytes, and fibrosis of the blood vessels. Amyloid is deposited in the arteriolar walls and extracellular space. Ischemic, autoimmune, or vascular mechanisms, and glial alterations have all been considered in the pathogensis of delayed cerebral radionecrosis. Some researchers have concluded that chemotherapeutic agents, such as methotrexate, may contribute to its production.

Research Organization:
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock
OSTI ID:
5500527
Journal Information:
South. Med. J.; (United States), Vol. 74:12
Country of Publication:
United States
Language:
English